Details for New Drug Application (NDA): 086263
✉ Email this page to a colleague
NDA 086263 describes DUVOID, which is a drug marketed by Chartwell Rx and is included in three NDAs. Additional details are available on the DUVOID profile page.
The generic ingredient in DUVOID is bethanechol chloride. There are eight drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the bethanechol chloride profile page.
The generic ingredient in DUVOID is bethanechol chloride. There are eight drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the bethanechol chloride profile page.
Summary for 086263
| Tradename: | DUVOID |
| Applicant: | Chartwell Rx |
| Ingredient: | bethanechol chloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 086263
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 25MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | AA | RLD: | No | ||||
Complete Access Available with Subscription
